[Breast cancer and hematological malignancy in the same patients].
Ten women with breast cancer and hematological malignancy (nine with double malignancy and one with triple malignancy) were analyzed. Mastectomy was performed on all patients in our hospital between July 1959 and June 1982 (23 years). Diagnoses of hematological malignancy were seven acute leukemias (five AML, two AMMoL), one CML, two lymphomas and one myeloma. Irradiation and chemotherapy were postoperative treatments in eight and three patients, respectively. The median interval between the first diagnosis and the second was four years and 10 months (one year and five months to 21 years and seven months). The median survival time from the first diagnosis was five years and eight months, while that from the second was six and a half months. In a clinical setting, it is difficult to ascertain the causative factors of multiple malignancy. Accumulation of additional patients is needed for further analysis.
D000328:Adult; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000601:surgery; D005260:Female; D006801:Humans; D007564:Japan; D007938:Leukemia / Q000453:epidemiology*; D008223:Lymphoma / Q000453:epidemiology*; D008408:Mastectomy; D008875:Middle Aged; D009101:Multiple Myeloma / Q000453:epidemiology; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology*